Mental Health Service Use Before and After a Suicidal Crisis Among Children and Adolescents in a United States National Medicaid Sample.


Journal

Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145

Informations de publication

Date de publication:
Historique:
received: 22 12 2020
revised: 21 04 2021
accepted: 25 04 2021
pubmed: 1 6 2021
medline: 18 9 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

Mental health follow-up after an emergency department (ED) visit for suicide ideation/attempt is a critical component of suicide prevention for young people. We analyzed 2009 to 2012 Medicaid Analytic EXtract for 62,139 treat-and-release ED visits and 30,312 ED-to-hospital admissions for suicide ideation/attempt among patients ages 6 to 17 years. We used mixed-effects logistic regression models to examine associations between patients' health care utilization prior to the ED visit and likelihood of completing a 30-day mental health follow-up visit. Overall, for treat-and-release ED visits, 49% had a 30-day follow-up mental health visit, and for ED-to-hospital admissions, 67% had a 30-day follow-up mental health visit. Having a mental health visit in the 30 days preceding the ED visit was the strongest predictor of completing a mental health follow-up visit (ED treat-and-release: adjusted odds ratio [AOR] 11.01; 95% confidence interval [CI] 9.82-12.35; ED-to-hospital AOR 4.60; 95% CI 3.16-6.68). Among those with no mental health visit in the 30 days preceding the ED visit, only 25% had an ambulatory mental health follow-up visit. Having a general health care visit in the 30 days preceding the ED visit had a much smaller association with completing a mental health follow-up visit (ED treat-and-release: AOR 1.17; 95% CI 1.09-1.24; ED-to-hospital AOR 1.25; 95% CI 1.17-1.34). Young people without an existing source of ambulatory mental health care have low rates of mental health follow-up after an ED visit for suicide ideation or attempt, and opportunities exist to improve mental health follow-up for youth with recent general health care visits.

Identifiants

pubmed: 34058404
pii: S1876-2859(21)00246-1
doi: 10.1016/j.acap.2021.04.026
pmc: PMC8429213
mid: NIHMS1721584
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1171-1178

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH115162
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH107452
Pays : United States

Informations de copyright

Copyright © 2021 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Références

Psychiatr Serv. 2013 Jul 1;64(7):653-9
pubmed: 23545716
Lancet. 2012 Mar 17;379(9820):1005-12
pubmed: 22305767
J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):213-222.e1
pubmed: 22265367
Early Interv Psychiatry. 2016 Dec;10(6):468-475
pubmed: 25639939
Sentinel Event Alert. 2016 Feb 24;(56):1-7
pubmed: 26915165
Am J Prev Med. 2014 Sep;47(3 Suppl 2):S229-34
pubmed: 25145744
Pediatrics. 2020 Jun;145(6):
pubmed: 32404433
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):769-75
pubmed: 23412882
Pediatrics. 2013 Mar;131(3):e903-11
pubmed: 23420919
MMWR Surveill Summ. 2018 Jun 15;67(8):1-114
pubmed: 29902162
Am J Public Health. 2018 Oct;108(10):1352-1354
pubmed: 30138071
Acad Psychiatry. 2003 Winter;27(4):277-82
pubmed: 14754851
JAMA Pediatr. 2018 Jun 1;172(6):596-598
pubmed: 29710063
Pediatrics. 2018 Aug;142(2):
pubmed: 30037977
Am J Psychiatry. 2013 Dec;170(12):1442-50
pubmed: 23897218
NCHS Data Brief. 2016 Apr;(241):1-8
pubmed: 27111185
JAMA Pediatr. 2020 Jun 1;174(6):620-622
pubmed: 32202603

Auteurs

Stephanie K Doupnik (SK)

Department of Pediatrics, Center for Pediatric Clinical Effectiveenss, and PolicyLab, Children's Hospital of Philadelphia (SK Doupnik and M Passarella), Philadelphia, Pa; The Leonard Davis Institute of Health Economics, The University of Pennsylvania (SK Doupnik, C Terwiesch, and SC Marcus), Philadelphia, Pa. Electronic address: DoupnikS@chop.edu.

Molly Passarella (M)

Department of Pediatrics, Center for Pediatric Clinical Effectiveenss, and PolicyLab, Children's Hospital of Philadelphia (SK Doupnik and M Passarella), Philadelphia, Pa.

Christian Terwiesch (C)

Wharton School (C Terwiesch), Philadelphia, Pa; The Leonard Davis Institute of Health Economics, The University of Pennsylvania (SK Doupnik, C Terwiesch, and SC Marcus), Philadelphia, Pa.

Steven C Marcus (SC)

School of Social Policy and Practice and Center for Mental Health (SC Marcus), Philadelphia, Pa; The Leonard Davis Institute of Health Economics, The University of Pennsylvania (SK Doupnik, C Terwiesch, and SC Marcus), Philadelphia, Pa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH